AQR Capital Management - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 140 filers reported holding HERON THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.52 and the average weighting 0.8%.

Quarter-by-quarter ownership
AQR Capital Management ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$126,450
-26.3%
122,767
-17.0%
0.00%
Q2 2023$171,623
-19.4%
147,951
+4.9%
0.00%
Q1 2023$213,026
+65.9%
141,077
+174.7%
0.00%
Q4 2022$128,400
-42.9%
51,360
-3.6%
0.00%
-100.0%
Q3 2022$225,000
-30.3%
53,268
+303.5%
0.00%
Q1 2019$323,000
-65.0%
13,202
-82.4%
0.00%
-100.0%
Q2 2014$924,00075,0000.00%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders